Moberg Pharma completes tap issue of SEK 215 million
STOCKHOLM, December 7th, 2016. Moberg Pharma AB (publ) (”Moberg Pharma”) (OMX: MOB) completes a tap issue of SEK 215M to its outstanding bond loan (ISIN: SE0007953989). The proceeds will be used as part financing of the acquisition of DermoPlast®.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, NEW ZEELAND, SOUTH AFRICA, HONG KONG OR SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL The tap issue has been placed at a price of 102.75 per cent of the nominal